Literature DB >> 18473674

Aptamers in immunotherapy.

Claudia M Dollins1, Smita Nair, Bruce A Sullenger.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18473674      PMCID： PMC3597343          DOI： 10.1089/hum.2008.045

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  63 in total

Review 1.  Subversion of host defense mechanisms by adenoviruses.

Authors:  H G Burgert; Z Ruzsics; S Obermeier; A Hilgendorf; M Windheim; A Elsing
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

2.  Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy.

Authors:  Ming-Jie Li; James Kim; Shirley Li; John Zaia; Jiing-Kuan Yee; Joseph Anderson; Ramesh Akkina; John J Rossi
Journal:  Mol Ther       Date:  2005-08-22       Impact factor: 11.454

3.  Pharmacologic and pharmacokinetic assessment of anti-TGFbeta2 aptamers in rabbit plasma and aqueous humor.

Authors:  Thomas G McCauley; Jeffrey C Kurz; Patricia G Merlino; Scott D Lewis; Madaline Gilbert; David M Epstein; H Nicholas Marsh
Journal:  Pharm Res       Date:  2006-01-19       Impact factor: 4.200

Review 4.  The roles of IFN gamma in protection against tumor development and cancer immunoediting.

Authors:  Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Cytokine Growth Factor Rev       Date:  2002-04       Impact factor: 7.638

5.  A mechanism for the control of protein synthesis by adenovirus VA RNAI.

Authors:  R P O'Malley; T M Mariano; J Siekierka; M B Mathews
Journal:  Cell       Date:  1986-02-14       Impact factor: 41.582

6.  Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.

Authors:  James O McNamara; Eran R Andrechek; Yong Wang; Kristi D Viles; Rachel E Rempel; Eli Gilboa; Bruce A Sullenger; Paloma H Giangrande
Journal:  Nat Biotechnol       Date:  2006-06-25       Impact factor: 54.908

7.  Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.

Authors:  Shawn E Lupold; Brian J Hicke; Yun Lin; Donald S Coffey
Journal:  Cancer Res       Date:  2002-07-15       Impact factor: 12.701

8.  High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I.

Authors:  T W Wiegand; P B Williams; S C Dreskin; M H Jouvin; J P Kinet; D Tasset
Journal:  J Immunol       Date:  1996-07-01       Impact factor: 5.422

Review 9.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

10.  DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers.

Authors:  C S M Ferreira; C S Matthews; S Missailidis
Journal:  Tumour Biol       Date:  2006-10-09
View more
  14 in total

Review 1.  Molecular aptamers for drug delivery.

Authors:  Weihong Tan; Hui Wang; Yan Chen; Xiaobing Zhang; Haizhen Zhu; Chaoyong Yang; Ronghua Yang; Chen Liu
Journal:  Trends Biotechnol       Date:  2011-08-06       Impact factor: 19.536

2.  Aptamer-mediated delivery of splice-switching oligonucleotides to the nuclei of cancer cells.

Authors:  Jonathan W Kotula; Elizabeth D Pratico; Xin Ming; Osamu Nakagawa; Rudolph L Juliano; Bruce A Sullenger
Journal:  Nucleic Acid Ther       Date:  2012-06       Impact factor: 5.486

Review 3.  Aptamers and aptamer targeted delivery.

Authors:  Amy C Yan; Matthew Levy
Journal:  RNA Biol       Date:  2009-07-18       Impact factor: 4.652

4.  A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor Effects.

Authors:  Wei-Yun Lai; Bo-Tsang Huang; Jen-Wei Wang; Pei-Ying Lin; Pan-Chyr Yang
Journal:  Mol Ther Nucleic Acids       Date:  2016-12-13

Review 5.  Design strategies for aptamer-based biosensors.

Authors:  Kun Han; Zhiqiang Liang; Nandi Zhou
Journal:  Sensors (Basel)       Date:  2010-05-04       Impact factor: 3.576

Review 6.  Aptamers and their biological applications.

Authors:  Kyung-Mi Song; Seonghwan Lee; Changill Ban
Journal:  Sensors (Basel)       Date:  2012-01-09       Impact factor: 3.576

7.  Aptamer-targeted antigen delivery.

Authors:  Brian C Wengerter; Joseph A Katakowski; Jacob M Rosenberg; Chae Gyu Park; Steven C Almo; Deborah Palliser; Matthew Levy
Journal:  Mol Ther       Date:  2014-03-31       Impact factor: 11.454

8.  Complexes of DNA with fluorescent dyes are effective reagents for detection of autoimmune antibodies.

Authors:  Ivana Domljanovic; Annika Carstens; Anders Okholm; Jørgen Kjems; Christoffer Tandrup Nielsen; Niels H H Heegaard; Kira Astakhova
Journal:  Sci Rep       Date:  2017-05-15       Impact factor: 4.379

Review 9.  Aptamer Hybrid Nanocomplexes as Targeting Components for Antibiotic/Gene Delivery Systems and Diagnostics: A Review.

Authors:  Navid Rabiee; Sepideh Ahmadi; Zeynab Arab; Mojtaba Bagherzadeh; Moein Safarkhani; Behzad Nasseri; Mohammad Rabiee; Mohammadreza Tahriri; Thomas J Webster; Lobat Tayebi
Journal:  Int J Nanomedicine       Date:  2020-06-17

10.  Commandeering a biological pathway using aptamer-derived molecular adaptors.

Authors:  Prabhat K Mallik; Kimi Nishikawa; Albert J T Millis; Hua Shi
Journal:  Nucleic Acids Res       Date:  2010-01-06       Impact factor: 16.971
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.